Your Health, We Care
Avatrombopag is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.
Avatrombopag is indicated for the treatment of thrombocytopenia in adult patients with chronic immunethrombocytopenia who have had an insufficient response to a previous treatment.
from FDA，2021.06
Avatrombopag is a novel oral thrombopoietin receptor agonist that has demonstrat···【more】
Release date：2025-01-17Recommended：133
Avatrombopag is an innovative drug that plays an important role in clinical trea···【more】
Release date：2025-01-17Recommended：140
Avatrombopag is a novel drug that has demonstrated unique therapeutic potential ···【more】
Release date：2025-01-17Recommended：104
